Table 3 Methylation status of the TGFBI promoter in primary and metastatic (lymph node and remote) lung cancer specimens
Source of lung cancer specimen | Number of methylated CpG sites | ||
|---|---|---|---|
|  | 0 | 5–10 | 16 |
Primary site (n = 36) | 22 (61.1%) | 12 (33.3%) | 2 (5.6%)* |
Lymph node (n = 10) | 4 (40.0%) | 2 (20.0%) | 4 (40.0%)* |
Remote metastasis (n = 4) | 2 (50.0%) | 0 (0.0%) | 2 (50.0%)* |